Crohn's Disease and Colitis Trial, Recruiting NCT05469607 Sponsor: Austin Health Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05469607
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with Crohn's disease
  • You have had surgery to remove a section of your bowel, and the two ends were joined together (called an anastomosis), with no visible signs of disease remaining after the operation
  • You previously had a temporary bag (ileostomy) after Crohn's surgery, and have since had that reversed, resulting in the bowel being rejoined with no visible abnormalities
  • You have Crohn's disease affecting the area around the back passage (perianal disease), as long as your surgery resulted in a rejoined bowel with no visible signs of disease
  • Your Crohn's disease diagnosis has been confirmed through a combination of clinical assessment, scans, camera tests, and tissue samples

Who may not be able to join:

  • The joined section of bowel cannot be reached using a standard camera test (colonoscopy)
  • There are still visible signs of disease remaining in the bowel after surgery
  • You have a permanent bowel bag (either an ileostomy or colostomy)
  • You have other health conditions or are currently too unwell to safely have a camera test (colonoscopy)
  • You are unable to give your consent to take part in the trial
  • The rejoined section of bowel cannot be reached during the camera test, even if it was expected to be accessible (confirm with trial site)
  • There is a suspected hole or tear in your bowel or digestive tract
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter De Cruz, MBBS PhD FRACP, Austin Health, Melbourne

Phone: +61 3 9496 6233

Australian sites

Austin Health, Melbourne, Victoria
+613 9496 5327

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Austin Health
Registry
ClinicalTrials.gov
Start date
8 July 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Safety and efficacy based on endoscopic recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov